EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression

Ruiyun Deng, Lili Zhu, Jun Jiang, Jing Chen, Hua Li

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2023.9931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Ruiyun Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Gene Expression Regulation, Neoplastic, Lung Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths, necessitating a deeper understanding of novel cell death pathways like cuproptosis. This study explored the relevance of cuproptosis-related genes in NSCLC and their potential prognostic significance. We analyzed the expression of 16 cuproptosis-related genes in 1017 NSCLC tumors and 578 Genotype-Tissue Expression (GTEx) normal samples from The Cancer Genome Atlas (TCGA) to identify significant genes. A risk model and prognostic nomogram were employed to identify the pivotal prognostic gene. Further in vitro experiments were conducted to investigate the functions of the identified genes in NSCLC cell lines. LIPT1, a gene for lipoate-protein ligase 1 enzyme, emerged as the central prognostic gene with decreased expression in NSCLC. Importantly, elevated LIPT1 levels were associated with a favorable prognosis for NSCLC patients. Overexpression of LIPT1 inhibited cell growth and enhanced apoptosis in NSCLC. We confirmed that LIPT1 downregulates the copper chaperone gene antioxidant 1 (ATOX1), thereby impeding NSCLC progression. Our study identified LIPT1 as a valuable prognostic biomarker in NSCLC as it elucidates its tumor-inhibitory role through the modulation of ATOX1. These findings offered insights into the potential therapeutic targeting of LIPT1 in NSCLC, contributing to a deeper understanding of this deadly disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungGene Expression Regulation, NeoplasticLung NeoplasmsFemaleHumansMaleMiddle AgedApoptosisBiomarkers, TumorCell Line, TumorCell ProliferationMolecular ChaperonesPrognosis

Substanzen

Biomarkers, TumorMolecular Chaperones

Autor:innen und Institutionen

  • Department of Intensive Care Unit, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • School of Life Sciences, Fudan University, Shanghai, China.
  • Department of Oncology, Shanghai Jing'an District Central Hospital, Shanghai, China.

Zitieren

APA

Deng, R., Zhu, L., Jiang, J., Chen, J., & Li, H. (2024). Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2023.9931

Vancouver

Deng R, Zhu L, Jiang J, Chen J, Li H. Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2023.9931

BibTeX
@article{Deng2024,
  author = {Deng, Ruiyun and Zhu, Lili and Jiang, Jun and Chen, Jing and Li, Hua},
  title = {Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2023.9931}
}
Kostenlos starten →